Results 91 to 97 of about 45,735 (97)

Ganglionitis and myelitis: myriad neurological manifestations of Hansen's disease. [PDF]

BMJ Case Rep, 2020
Bafna P, Sahoo RR, Manoj M, Wakhlu A.
europepmc   +1 more source

Relevance of reporting leprosy related disability at the completion of multi drug therapy: A 5-year retrospective analysis of disability in persons affected by leprosy at ALERT Hospital Ethiopia. [PDF]

PLoS Negl Trop Dis
Tegene BA, Atnafu TA.
europepmc   +1 more source

Case Report: Hypercalcemia in an Older Patient with Type I Lepra Reaction. [PDF]

Am J Trop Med Hyg, 2020
Rao AR, Aryal A, Thakral M, Painkra B, Chakrawarty A, Dey AB.   +5 more
europepmc   +1 more source

Case Report: Rifampicin-Induced Thrombocytopenia in a Patient with Borderline Lepromatous Leprosy. [PDF]

Am J Trop Med Hyg, 2020
Shui T, Shi C, Jing Z, Yang D, Zhu J.
europepmc   +1 more source

Late relapses in leprosy patients in Brazil: 10-year post-trial of uniform multidrug therapy (U-MDT/CT-BR). [PDF]

Braz J Infect Dis
Penna GO, Pontes MAA, Talhari S, Gonçalves HS, Talhari C, Pessoa AS, Pedroza V, Bührer-Sékula S, Stefani MMA, Penna MLF.   +9 more
europepmc   +1 more source

An update of the diagnosis, treatment, and prevention of leprosy: A narrative review. [PDF]

Medicine (Baltimore)
Huang CY, Su SB, Chen KT.
europepmc   +1 more source

The anti-leprosy drug clofazimine reduces polyQ toxicity through activation of PPARγ. [PDF]

EBioMedicine
Li X, Hernandez I, Koyuncu S, Kis B, Häggblad M, Lidemalm L, Abbas AA, Bendegúz S, Göblös A, Brautigam L, Lucas JJ, Carreras-Puigvert J, Hühn D, Pircs K, Vilchez D, Fernandez-Capetillo O.   +15 more
europepmc   +1 more source